Occupational and public exposures in RIT of brain tumors in Cuba

Occupational and public exposures in RIT of brain tumors in Cuba

The first phase of the clinical trial using the humanized monoclonal antibody h-R3 (Nimotuzumab) labelled with , for radioimmunotherapy of brain malignant was performed during the period 2002-2005 in Cuba. The aim of this work was to analyze data from the radiological surveillance of this research c...

Full description

Bibliographic Details
Main Authors: Zayda Haydeé Amador Balbona, Fernando Enrique Ayra Pardo, Mirta Bárbara Torres Berdeguez
Format: Article
Language:English
Published: Centro de Gestión de la Información y Desarrollo de la Energía (CUBAENERGIA) 2009-01-01
Series:Nucleus
Subjects:
radioimmunotherapy, rhenium 188, occupational exposure, brain neoplasms, radiation doses, radiation monitoring, clinical trials
Online Access:http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/517

Internet

http://nucleus.cubaenergia.cu/index.php/nucleus/article/view/517

Similar Items